Form 4: Guardant Health CFO Reports Stock Transaction
Insider Transaction (Form 4)
Michael Brian Bell, Chief Financial Officer of Guardant Health, Inc., reported multiple transactions in common stock on October 1, 2026.
Summary
- Option exercise/conversion: acquired 2,085 Common Stock on October 1, 2026; holds 53,901 after (Direct).
- Option exercise/conversion: acquired 3,324 Common Stock on October 1, 2026; holds 57,225 after (Direct).
- Option exercise/conversion: acquired 1,871 Common Stock on October 1, 2026; holds 59,096 after (Direct).
- Tax/exercise-price withholding: disposed of 3,914 Common Stock at $174.75 ($683,972) on October 1, 2026; holds 55,182 after (Direct).
- Option exercise/conversion: disposed of 2,085 Restricted Stock Units on October 1, 2026 (Direct).
- Option exercise/conversion: disposed of 3,324 Restricted Stock Units on October 1, 2026; holds 13,296 after (Direct).
- Option exercise/conversion: disposed of 1,871 Restricted Stock Units on October 1, 2026; holds 11,222 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Michael Brian Bell — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Option exercise/conversion | Common Stock | 2,085 | — | — | 53,901 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 3,324 | — | — | 57,225 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,871 | — | — | 59,096 |
| 2026-10-01 | Tax/exercise-price withholding | Common Stock | 3,914 | $175 | $684.0K | 55,182 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 2,085 | — | — | 0 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 3,324 | — | — | 13,296 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,871 | — | — | 11,222 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Option exercise/conversion (2,085 shares) |
| 2026-10-01 | Option exercise/conversion (3,324 shares) |
| 2026-10-01 | Option exercise/conversion (1,871 shares) |
| 2026-10-01 | Tax/exercise-price withholding (3,914 shares) |
| 2026-10-01 | Option exercise/conversion (2,085 shares) |
| 2026-10-01 | Option exercise/conversion (3,324 shares) |
| 2026-10-01 | Option exercise/conversion (1,871 shares) |
Keywords
insider transaction, Form 4, GH, Guardant Health, Inc., neutral, Michael Brian Bell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.